BYAKANGELICIN
Byakangelicin is a furanocoumarin that acts as an aldose reductase inhibitor. It has shown potential in research models for diabetic complications, such as sugar cataracts and neuropathy, making it a candidate for further drug development.
Product Specifications
CAS Number
482-25-7
Product Name Alternative
BYAKANGELICIN, Aldose reductase, inhibit, Inhibitor
Field of Research
Metabolism Research
Purity
≥95% (May vary between batches)
Solubility
DMSO:45 mg/mL (134.6 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.98 mM)
Smiles
[H][C@@] (O) (COc1c2occc2c (OC) c2ccc (=O) oc12) C (C) (C) O
Molecular Formula
C17H18O7
Molecular Weight
334.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS649877-01 0.2 mL
Ppm1h, ID (Ppm1h, Kiaa1157, Protein phosphatase 1H)
Sign In for Pricing
View Details MBS649877-02 5x 0.2 mL
Ppm1h, ID (Ppm1h, Kiaa1157, Protein phosphatase 1H)
Sign In for Pricing
View Details 
771131 8 PCS/CS
2 Chambers, 2 Wide Mouth Caps, Non-TC, Sterile, Double Bag Package, 1 pc/pack, 8 packs/case, 8 pcs/case
Sign In for Pricing
View Details 
orb2617133 100 µg
Insulin Receptor/INSR Rabbit Polyclonal Antibody (HRP)
Sign In for Pricing
View Details